Compare Smith & Nephew plc (SNN) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Smith & Nephew plc trades at $30.05 (market cap $12.54B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.49. The key difference: Smith & Nephew plc pays a 2.65% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | XDTE | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $38.70 | $44.76 |
52-Week Low | $28.73 | $36.00 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $29.87, down 0.71% on the day, with a bearish technical signal. The company reported Q2 2026 revenue growth of 1.6%, below expectations, leading to a reduced full-year outlook. Fundamentals show improvement with 2025 revenue of $6.16B and net income of $625M, yielding a 10.08% margin, though recent earnings have been mixed. The balance sheet remains solid with $619M in cash and a debt-to-asset ratio of 29.75% for 2025.
The outlook is cautious due to near-term operational weakness, particularly in U.S. Orthopaedics, offset by innovation in robotics and wound care. Risks include execution challenges and competitive pressures, while analyst sentiment is predominantly Hold. The stock's valuation appears reasonable with a P/E of 20.41, but growth catalysts are needed for significant upside.
XDTE trades at $39.48, up 0.03% with a bullish technical signal from moving averages, though RSI indicates potential overbought conditions. The ETF focuses on weekly income via covered calls on the S&P 500, with recent dividends averaging around $0.15 per week. Financial ratios are not disclosed, and news highlights high yield claims but questions sustainability.
Outlook hinges on income strategy appeal amid market stability; opportunities include consistent payouts, but risks involve NAV erosion and fee drag. Investor caution is warranted due to mixed sentiment and reliance on options premiums.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
